- Home
- GMGI vs COEP Comparison
GMGI vs COEP Comparison
Compare GMGI & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GMGI | COEP |
|---|---|---|
| Founded | 2008 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.8M | 100.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GMGI | COEP |
|---|---|---|
| Price | $0.64 | $12.25 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 236.3K | 63.6K |
| Earning Date | 03-23-2026 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $179,142,103.00 | $500,996.00 |
| Revenue This Year | $25.59 | N/A |
| Revenue Next Year | $14.27 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 37.24 | N/A |
| 52 Week Low | $0.57 | $6.26 |
| 52 Week High | $2.50 | $21.41 |
Technical Indicators
Market Signals| Indicator | GMGI | COEP |
|---|---|---|
| Relative Strength Index (RSI) | 43.61 | 42.63 |
| Support Level | $0.57 | $10.49 |
| Resistance Level | $0.78 | $15.94 |
| Average True Range (ATR) | 0.08 | 1.22 |
| MACD | -0.00 | -0.17 |
| Stochastic Oscillator | 32.24 | 33.58 |
Price Performance
Historical ComparisonAbout GMGI Golden Matrix Group Inc.
Golden Matrix Group Inc is an established gaming technology company. The company develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers. The company operates in three reportable segments; MeridianBet Group, GMAG, RKings & CFAC. The MeridianBet Group segment earns majority revenue. The company operates in UK, Europe, Asia Pacific, Central and South America, Australia and Africa. It offers configurable and scalable iGaming platforms and operate some of the industry's iconic brands, including MexPlay, GM-AG, and others.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.